India, Aug. 17 -- image credit- freepik

Bengaluru-based startup 4baseCare, a precision oncology company building genomic and clinical intelligence for diverse populations, has announced the launch of TARGT Indiegene(R) V2, the next generation of its comprehensive genomic profiling (CGP) test for cancer biomarker testing.

The journey began on 15 August 2021, when 4baseCare launched the first Indiegene developed from insights generated through Indian tumour genomics and with the ambition of making comprehensive cancer profiling more accessible. Five years of continuous innovation, clinical experience and genomic insights have now led to Indiegene V2.

With 2,206 genes, V2 significantly expands the genomic breadth of the original panel. Mo...